Functional computed tomography in oncology.

Functional Computed Tomography (CT) describes the use of existing technologies and conventional contrast agents to capture physiological parameters that reflect the vasculature within tumours and other tissues. The technique is readily incorporated into routine conventional CT examinations and, in tumours, the physiological parameters obtained provide an in-vivo marker of angiogenesis. As well as providing a research tool, functional CT has clinical applications in tumour diagnosis, staging, risk stratification and therapy monitoring, including the characterisation of pulmonary nodules, detection of occult hepatic metastases, grading of cerebral glioma and monitoring of anti-angiogenesis drugs. With the recent commercial availability of appropriate software and the development of multislice CT systems, functional CT is poised to make a significant impact upon the imaging of patients with cancer.

[1]  M. P. Hayball,et al.  Assessment of quantitative computed tomographic cerebral perfusion imaging with H2150 positron emission tomography , 2000, Neurological research.

[2]  S. Leurgans,et al.  Tumor angiogenesis in primary and metastatic colorectal cancers , 1996, Diseases of the colon and rectum.

[3]  S J Swensen,et al.  Lung nodule enhancement at CT: prospective findings. , 1996, Radiology.

[4]  B. Carey,et al.  Quantitative Imaging in Oncology , 1996 .

[5]  A K Dixon,et al.  BW12C perturbs normal and tumour tissue oxygenation and blood flow in man. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  W P Dillon,et al.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.

[7]  K. Miles,et al.  Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. , 2001, Radiology.

[8]  H. Honda,et al.  Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. , 1995, Radiology.

[9]  A K Dixon,et al.  Functional images of hepatic perfusion obtained with dynamic CT. , 1993, Radiology.

[10]  D. Naidich,et al.  Solitary Pulmonary Nodules: CT-Bronchoscopic Correlation , 1988 .

[11]  Blood-brain barrier and blood volume imaging of cerebral glioma using functional CT: a pictorial review. , 1999, European journal of radiology.

[12]  M Kono,et al.  Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. , 1997, Radiology.

[13]  J D Pickard,et al.  Reproducibility of quantitative CT perfusion imaging. , 2001, The British journal of radiology.

[14]  L. Axel.  Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. , 1980, Radiology.

[15]  K. Miles,et al.  Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. , 1997, Radiology.

[16]  N. Hattori,et al.  Tumor Blood Flow Measured Using Dynamic Computed Tomography , 1994, Investigative radiology.

[17]  W. W. Li.  Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. , 2000, Academic radiology.

[18]  E. Fishman,et al.  Application of CT in the investigation of angiogenesis in oncology. , 2000, Academic radiology.

[19]  K Miyasaka,et al.  Tumor Angiogenesis and Dynamic CT in Lung Adenocarcinoma: Radiologic–Pathologic Correlation , 2001, Journal of computer assisted tomography.

[20]  N. Müller,et al.  Lung nodule enhancement at CT: multicenter study. , 2000, Radiology.

[21]  James S. Killius,et al.  Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases? , 2000, Radiology.

[22]  M. Brawer,et al.  Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity , 1994, Cancer.

[23]  Tran,et al.  9:00-9:15. Antiangiogenic Treatment with Endostatin Results in Uncoupling of Blood Flow and Glucose Metabolism in Human Tumors. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[24]  M. P. Hayball,et al.  Colour perfusion imaging: a new application of computed tomography , 1991, The Lancet.

[25]  M. Lipton,et al.  Cine-Computed Tomographic Assessment of Regional Renal Blood Flow , 1990, Acta radiologica.

[26]  K. Miles,et al.  Hepatic metastases: the value of quantitative assessment of contrast enhancement on computed tomography. , 1999, European journal of radiology.

[27]  J. Rock,et al.  Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. , 1998, Journal of neurosurgery.

[28]  B. Brundage,et al.  Measurement of myocardial blood flow by ultrafast computed tomography. , 1987, Circulation.

[29]  R. Craen,et al.  A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. , 2000, AJNR. American journal of neuroradiology.

[30]  R. Craen,et al.  Dynamic CT measurement of cerebral blood flow: a validation study. , 1999, AJNR. American journal of neuroradiology.

[31]  W. K. Loftus,et al.  Lung nodule enhancement at CT. , 1997, Radiology.

[32]  M. Lipton,et al.  Contrast Bolus Dynamic Computed Tomography for the Measurement of Solid Organ Perfusion , 1993, Investigative radiology.

[33]  C. Angeletti,et al.  Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. , 1997, Journal of the National Cancer Institute.

[34]  A. Santin.  Lymph node metastases , 2000, Cancer.

[35]  J. Ellis,et al.  Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. , 1997, Radiology.

[36]  K. Miles,et al.  CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. , 1999, Journal of computer assisted tomography.

[37]  K. Miles,et al.  Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. , 1999, European journal of radiology.

[38]  A L Baert,et al.  Non-invasive tumour perfusion measurement by dynamic CT: preliminary results. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  F Frouin,et al.  Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. , 2001, Radiology.

[40]  M. Jinzaki,et al.  Double-Phase Helical CT of Small Renal Parenchymal Neoplasms: Correlation with Pathologic Findings and Tumor Angiogenesis , 2000, Journal of computer assisted tomography.

[41]  R Sinnatamby,et al.  In vivo assessment of neovascularization of liver metastases using perfusion CT. , 1998, The British journal of radiology.